Work

Supplementary Table S1 from JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non–small Cell Lung Cancers

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table 1. Clonogenic survival of NSCLC cell lines after cytotoxic therapy.

DOI: 10.1158/1535-7163.22504798.v1

Authors: Sean P. Pitroda, Melinda E. Stack, Gene-Fu Liu, Sui-Sui Song, Lucy Chen, Hua Liang, Akash D. Parekh, Xiaona Huang, Paul Roach, Mitchell C. Posner, Ralph R. Weichselbaum, Nikolai N. Khodarev

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362622709

Cites:

Cited by:

Related to: 10